Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nobelzin for prevention of severe oral mucositis during chemoradiotherapy in oral cancer
jRCTs061230046Recruiting
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of zinc acetate in mouth cancer and stomatitis, sponsored by Nobelpharma Co., Ltd. Primary endpoint: Incidence of severe oral mucositis. Started Mar 2024; status: recruiting.
02
Drugs
zinc acetate
03
Conditions
mouth cancerstomatitis
Beyond the preview
Go deeper on jRCTs061230046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061230046.